Form D · Biotechnology
Personal Genome Diagnostics Inc.
Baltimore, MD · CIK 0001530958
Offering snapshot reported Feb 23, 2021 · SEC filing
- Reported sold
- $97.7M Offering amount: $98.3M
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2021 | Initial | $97,729,418 | No comparison | 38 | SEC filing |
| May 26, 2020 | Initial | $2,750,000 | No comparison | 2 | SEC filing |
| Jun 24, 2019 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Oct 30, 2017 | Initial | $65,367,412 | No comparison | 12 | SEC filing |
| Nov 6, 2015 | Initial | $20,451,998 | No comparison | 22 | SEC filing |
| Jun 3, 2015 | Initial | $4,322,000 | No comparison | 18 | SEC filing |
| Mar 17, 2014 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Sep 23, 2011 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-390203
Source: Form D, filed Feb 23, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sam Angiuoli | Executive |
| Samuel Anguioli | Executive |
| Sam Anguioli | Executive |
| Megan Bailey | Director, Executive |
| Jeff Boschwitz | Executive |
| Cindy Caccuro | Executive |
| Jack Crowley | Executive |
| Felix Dawson | Director |
| Luis Diaz | Executive |
| Luis A. Diaz, Jr. | Director |
| Jason Fuller | Director |
| Scott Gotshall | Executive |
| Sian Jones | Executive |
| Lisa Kann | Executive |
| Kenneth W. Kinzler | Promoter |
| Justin Klein | Director |
| James La France | Director |
| Lily Li | Director |
| Anthony Newton | Executive |
| Garry Nicholson | Director |
| Kavita Patel | Director |
| Kevin Reidy | Director |
| Mark Sausen | Executive |
| William Stevens | Executive |
| Victor Velculescu | Director |
| Bert Vogelstein | Promoter |
| Douglas Ward | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2809 Boston Street Suite 503
Baltimore, MD, 21224
Baltimore, MD, 21224